RAFAEL HOLDINGS, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
RAFAEL HOLDINGS, INC. (RFL) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $0 as of 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2023-06-13
- 2023-04-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2023-01-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2022-10-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
- 2022-07-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $0.00.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed |
|---|---|---|
| 2023-04-30 | $0.00 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $0.00 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $0.00 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $0.00 10-K · filed 2022-10-31 | |
| 2022-04-30 | $97.00K 10-Q · filed 2023-06-13 | |
| 2022-01-31 | $222.00K 10-Q · filed 2023-03-14 | |
| 2021-10-31 | $347.00K 10-Q · filed 2022-12-13 | $347.19K 10-Q · filed 2021-12-15 |
| 2021-07-31 | $472.18K 10-K · filed 2021-10-18 | |
| 2020-10-31 | $0.00 10-Q/A · filed 2022-02-28 | |
| 2020-07-31 | $0.00 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |